Best General Drug Manufacturer Stocks to Buy Now (2026)Top general drug manufacturer stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best general drug manufacturer stocks to buy now. Learn More.
Industry: Drug Manufacturers - Gene...
A
General Drug Manufacturers is Zen Rated A and is the 15th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GSK | GSK PLC | $116.69B | $58.07 | N/A | N/A | N/A | N/A | -5.44% | -16.48% | 39.93% | 10.70% | |||
| BMY | BRISTOL MYERS SQUIBB CO | $124.43B | $61.10 | $62.00 | 1.47% | Buy | 13 | -4.62% | 17.47% | 53.93% | 11.06% | |||
| GILD | GILEAD SCIENCES INC | $178.48B | $143.77 | $151.77 | 5.56% | Strong Buy | 13 | 5.03% | 14.58% | 61.29% | 23.57% | |||
| LLY | ELI LILLY & CO | $964.13B | $1,022.02 | $1.19k | 16.48% | Strong Buy | 18 | 18.93% | 26.57% | 199.20% | 46.99% | |||
| ABBV | ABBVIE INC | $397.29B | $224.69 | $253.06 | 12.63% | Strong Buy | 16 | 9.24% | 96.27% | -1,046.87% | 25.55% | |||
| SNY | SANOFI | $117.92B | $48.35 | $58.00 | 19.96% | Strong Buy | 1 | -1.24% | 37.34% | 15.27% | 8.60% | |||
| GRFS | GRIFOLS SA | $6.16B | $8.96 | $10.00 | 11.61% | Hold | 1 | 4.47% | 80.52% | 15.62% | 4.29% | |||
| AZN | ASTRAZENECA PLC | $316.35B | $203.98 | N/A | N/A | N/A | N/A | 7.28% | 25.79% | 45.91% | 19.59% | |||
| MRK | MERCK & CO INC | $294.96B | $119.30 | $123.21 | 3.28% | Buy | 14 | 5.02% | 17.79% | 48.64% | 18.69% | |||
| AMGN | AMGEN INC | $204.48B | $379.33 | $353.64 | -6.77% | Buy | 14 | 3.26% | 18.21% | 158.43% | 15.14% | |||
| JNJ | JOHNSON & JOHNSON | $586.74B | $243.47 | $231.94 | -4.74% | Buy | 16 | 6.31% | 7.23% | 44.17% | 18.08% | |||
| BIIB | BIOGEN INC | $27.59B | $188.02 | $198.05 | 5.34% | Buy | 19 | -0.99% | 23.87% | 14.55% | 9.02% | |||
| PFE | PFIZER INC | $154.10B | $27.10 | $27.56 | 1.68% | Hold | 9 | -4.01% | 25.95% | 14.26% | 5.92% | |||
| AMRN | AMARIN CORP PLC | $293.59M | $14.12 | N/A | N/A | N/A | N/A | -9.80% | N/A | 101.68% | 70.72% | |||
| NVS | NOVARTIS AG | $315.82B | $165.51 | $118.00 | -28.71% | Strong Sell | 1 | 4.23% | 15.02% | 47.88% | 19.91% | |||
| OGN | ORGANON & CO | $1.88B | $7.23 | $9.67 | 33.71% | Strong Sell | 3 | 0.97% | 81.36% | 131.11% | 7.66% | |||
| SCLX | SCILEX HOLDING CO | $61.59M | $8.12 | N/A | N/A | N/A | N/A | 170.24% | N/A | -46.93% | 30.57% | |||
| MIRA | MIRA PHARMACEUTICALS INC | $55.70M | $1.33 | N/A | N/A | N/A | N/A | N/A | N/A | -101.84% | -100.72% | |||
| MDCX | MEDICUS PHARMA LTD | $29.96M | $1.36 | $27.00 | 1,885.29% | Strong Buy | 1 | N/A | N/A | -2,616.99% | 238.71% | |||
| NSRX | NASUS PHARMA LTD | $45.95M | $5.10 | $20.50 | 301.96% | Strong Buy | 2 | N/A | N/A | N/A | -1,697.09% |
General Drug Manufacturer Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.